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OBJECTIVES This study was designed to determine whether arterial remodeling and plaque vulnerability
are influenced by systemic factors.
BACKGROUND Atherosclerotic luminal narrowing is caused by gradual plaque growth and arterial remodel-
ing. In the acute phase, luminal narrowing may be accelerated by acute thrombus formation,
usually precipitated by rupture of a vulnerable plaque.
METHODS Femoral arteries were obtained from elderly individuals at autopsy. Pairs of atherosclerotic
femoral arteries from 42 individuals were examined. The arteries were divided in 1-cm
intervals. Plaque size, the mode of arterial remodeling and histopathologic characteristics of
plaque vulnerability (lipid-rich core and plaque inflammation) were compared between right
and left femoral arteries obtained from the same individual. A role for systemic factors was
assumed if a phenomenon was equally present in both arteries.
RESULTS There was concordance in average plaque size (r2 5 0.5, p , 0.001), expansive remodeling
(kappa 5 0.42, p 5 0.007) and occurrence of plaques containing a large lipid-rich core
(kappa 5 0.60, p 5 0.001), but no concordance in plaque inflammation (kappa 5 0.067, p 5
0.61) between right and left arteries.
CONCLUSIONS These results suggest that not only the amount of atherosclerosis, but also arterial remodeling
and lipid deposition in plaques, are influenced by systemic factors. The nonhomogeneous
distribution of inflammation in atherosclerotic arteries supports the hypothesis that plaque
inflammation is locally affected. (J Am Coll Cardiol 2001;38:718–23) © 2001 by the
American College of Cardiology
Atherosclerotic plaque formation is a chronic process start-
ing early in life. Luminal narrowing by atherosclerosis is
determined by gradual plaque growth and arterial remodel-
ing. Plaque accumulation can be compensated for by expan-
sive remodeling of the vessel wall (1). Failure to enlarge and
even constrictive remodeling also frequently occur (2).
Examples of acute manifestations of atherosclerosis are
acute myocardial infarction and unstable angina pectoris.
Rupture of the plaque surface and subsequent luminal
thrombus formation is probably the most important mech-
anism underlying these acute syndromes (3). The risk of
plaque rupture depends on plaque composition rather than
on plaque size (3). Histopathologic data have led to the
concept that a soft lipid-rich core, a thin cap and inflam-
mation in cap and shoulders of the plaque make a plaque
vulnerable for rupture (3,4).
Atherosclerotic lesions preferentially develop in lesion-
prone areas near bifurcations (determined by local flow-
related factors), but the gradual growth of plaques is
predominantly determined by global or systemic factors
such as gender, age, hypercholesterolemia and hypertension.
However, it is unknown to what extent arterial remodeling
and plaque vulnerability are determined by systemic factors.
The femoral artery is a long (30 cm) artery prone to
develop atherosclerotic disease, with only minor tapering,
which makes this artery ideally suited to study not only
plaque morphology but also arterial remodeling. In the
present study we assessed whether the presence of plaque-
related features (size, remodeling, vulnerability) in one
femoral artery was associated with their presence in the
contralateral artery obtained from the identical individual. A
phenomenon that is systemically influenced was assumed to
be equally prevalent in both arteries, whereas unilateral
prevalence might indicate a more locally determined phe-
nomenon.
METHODS
Human femoral arteries. Plaque size, arterial remodeling
and plaque vulnerability were assessed in bilateral femoral
arteries. We assumed that right and left femoral arteries are
relatively similar before being influenced by potential sys-
temic factors. Ninety-six femoral arteries of 48 donated
corpses (history of cardiovascular disease unknown) were
pressure fixed in situ within 24 h after death using formal-
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dehyde 4% (pressure: age 1 100 mm Hg). The femoral
arteries were divided in 1-cm segments (n 5 2,688). Each
1-cm segment was cut in two 0.5-cm segments. The
matching cutting faces were used for morphometric analysis
and (immuno)histochemical staining, respectively (5). Of
every two 0.5-cm segments obtained from a 1-cm segment,
one 0.5-cm segment was stained with Lawson’s elastic tissue
stain and studied under magnification. Staining of the entire
0.5-cm segment avoided cutting artifacts attributable to
histologic sectioning before analysis. The macroscopic im-
ages of the cross-sections were recorded on sVHS videotape
with a 3CCD video camera for analysis of geometry. The
cross-sections recorded on videotape were analyzed with a
digital video analyzer. Subsequently, the lumen area and the
area encompassed by the internal elastic lamina (IEL) area
were measured. Plaque area was calculated as IEL area
minus lumen area. Cross-sectional narrowing was defined as
(plaque area/IEL area) 3 100%. To avoid inclusion of
arteries without variation in plaque size, arteries with minor
atherosclerosis were excluded. If one or both arteries of an
individual did not reveal cross-sections with cross-sectional
narrowing of at least 30% (arbitrary limit), this individual
was excluded from the study (n 5 6). The 84 arteries of the
remaining 42 individuals (27 men and 15 women, average
age 83 6 8 years) were used to calculate the average arterial
plaque size and to correlate plaque area and IEL area.
Plaque size. Average arterial plaque size was defined as the
average value of all plaque areas in an artery. Before
calculation of the average arterial plaque size, all measured
values of an artery were adjusted to correct for differences in
arterial size among individuals. A correction factor was
calculated for each individual as follows: (average IEL area
of all arteries of all individuals)/(average IEL area of both
arteries of one individual). Between right and left arteries,
the correlation in average plaque size was studied.
Arterial remodeling. For each artery, regression analysis
was performed to assess the relation between plaque area
and IEL area (a measure of structural expansive remodeling)
(1,6). Arteries were categorized as with or without a
significant correlation between plaque and IEL area. The
presence or absence of a significant correlation between
plaque and IEL area was compared between right and left
arteries.
Plaque vulnerability. In 30 randomly selected individuals
the presence of histopathologic features related to vulnerable
plaques (a large atheroma and inflammation) was deter-
mined in right and left femoral arteries. We have reported
on the CD68 staining of 36 of these arteries (18 pairs) (5).
Staining was performed in the 0.5-cm segments that
matched the segments used for morphometric analysis. Of
each artery, six arterial segments were selected for additional
(immuno)histochemical staining. Of each artery, the seg-
ments that fulfilled the following criteria were selected for
additional staining: smallest lumen area, largest lumen area,
smallest plaque area, largest plaque area, smallest IEL area
and largest IEL area. Thirty-one segments selected accord-
ing to the six categories appeared to be identical for two
categories. Thus, a total of 329 segments obtained from 60
arteries of 30 individuals were selected for staining.
Segments were embedded in paraffin, sectioned at 5 mm
thickness and mounted on different microscopic slides.
Serial sections were stained. To detect collagen, sections
were stained with picrosirius red. A mouse antihuman
CD68 monoclonal antibody (Dakopatts, Glostrup, Den-
mark) was used to visualize the presence of macrophages.
To make the CD68 epitope accessible for the anti-CD68
monoclonal antibody, the transverse cross-sections were
boiled in sodium citrate buffer (10 mM, pH 6.0) for 15 min.
An antibody against CD45RO (Dakopatts) was used to
detect T-lymphocytes. Immunohistochemical detection of
the preferred epitopes was performed according to the
indirect horseradish peroxidase and alkaline phosphatase
technique for CD68 and CD45RO, respectively.
The percentage atheroma of the total area of the plaque was
visually estimated using picrosirius red staining and polarized
light. Two groups were considered on the basis of percentage
of atheroma in the plaque: lipid-rich core occupying , or
$40% of total plaque area (4). Thrombus formation is most
likely to occur because of inflammation of the cap and cap
rupture near the shoulder of the plaque (3,7). Therefore,
analysis of inflammatory cells focused on these regions within
the plaque. Staining of CD68 (or CD45RO) was considered
positive if clusters of .10 stained cells were observed. Presence
of superficial inflammation was defined as staining of CD68
and/or CD45RO in cap and/or shoulder. All stained cross-
sections were analyzed independently by two observers. If the
two observers disagreed on classification, a third observer
analyzed the cross-section. Consensus was reached in all cases.
After the boiling procedure for the CD68 staining, the
immunohistochemical staining of nine cross-sections (from
four individuals) could not be analyzed because of artifacts.
These four individuals were excluded for the analysis of
inflammatory cells.
Statistics. The correlation between right and left arteries of
continuous variables was calculated by linear regression
analysis. Kappa statistics were used to calculate whether
presence of a categorized variable in an artery was associated
with its presence in the (contralateral) artery obtained from
the same individual. Measured values are presented as
mean 6 standard deviation. A value of p , 0.05 was
considered statistically significant.
RESULTS
A total of 2,373 segments were obtained from 84 arteries of
42 individuals (28 6 5 per artery). The mean measured
Abbreviations and Acronyms
CRP 5 C-reactive protein
IEL 5 internal elastic lamina
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lumen area, IEL area, plaque area and cross-sectional
narrowing were 21.3 6 10.3 mm2, 33.6 6 12.8 mm2,
12.3 6 6.5 mm2 and 37.5 6 15.9%, respectively.
Plaque size. Average plaque size in the right femoral artery
correlated strongly with average plaque size in the left
femoral artery (r2 5 0.5, p , 0.001, Fig. 1).
Arterial remodeling. The relation between plaque area and
IEL area is considered to represent expansive remodeling
(1,6). In 25 of 42 individuals, a significant correlation
between plaque area and IEL area was found in both
femoral arteries. In 7 of 42 individuals, no significant
correlation between plaque area and IEL area was found in
both arteries. Thus, in 32 of 42 individuals (76%) the
presence or absence of a significant correlation between
plaque area and IEL area was similar in the right and left
artery (Table 1, kappa 5 0.42, p 5 0.007). Figure 2A shows
an example of an individual with a significant increase of
IEL area in response to plaque formation in the right and
left artery. Figure 2B shows an example of an individual
without enlargement of the IEL area in response to plaque
formation in both arteries.
Within the individual, the slopes of the correlation
between plaque area and IEL area appeared to be concor-
dant in the right and left femoral artery. Linear regression
analysis revealed a correlation between the slopes of the
right and left arteries (y 5 0.6x 1 0.3, r2 5 0.2, p 5 0.002).
Lipid-rich plaques. The number of plaques with a lipid-
rich core that occupied $40% of the total plaque (Fig. 3),
irrespective of the presence of inflammation, was compared
between left and right femoral arteries. A total of 90 plaques
with a lipid-rich core were detected (per artery: 1.5 6 1.3,
median 1, range 0 to 5; per individual: 2.2 6 2.5, median
2.5, range 0 to 7). There was concordance in the number of
plaques with a lipid-rich core between right and left arteries
(kappa 0.60, p 5 0.001, Table 2).
Inflammation. The presence of inflammation in cap and
shoulders (Fig. 3), irrespective of atheroma size, was com-
pared between left and right femoral arteries. A total of 137
plaques with inflammation were observed (per artery: 2.6 6
1.5, median 5 3, range 0 to 6; per individual: 4.6 6 2.9,
median 4.5, range 0 to 12). There was no concordance in
number of plaques with inflammation between right and left
femoral arteries (kappa 0.067, p 5 0.61, Table 3).
DISCUSSION
In the present study we investigated whether atherosclerotic
remodeling and plaque vulnerability are systemically deter-
Figure 1. Plot of average plaque size in left versus right femoral arteries.
Plaque size left indicates average plaque size of the left femoral artery. The
average arterial plaque size was defined as the average value of all plaque
areas in an artery.
Table 1. Presence or Absence of Correlation Between Plaque
Area and IEL Area in Right and Left Femoral Arteries
Left Femoral Artery
Right Femoral Artery
Significant
Correlation
No
Correlation
Significant correlation 25 (60%) 5 (12%)
No correlation 5 (12%) 7 (17%)
Agreement 76%, kappa 5 0.42 (p 5 0.007).
IEL area 5 area encompassed by internal elastic lamina.
Figure 2. (A) Example of an individual with a significant correlation
between plaque area and internal elastic lamina (IEL) area in both right
and left femoral artery. Plot of IEL area versus plaque area. This individual
shows significant enlargement in response to plaque formation in both
arteries. (B) Example of an individual without correlation in both arteries.
This individual shows no enlargement in response to plaque formation in
both arteries.
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mined. For this purpose, plaque-related features were com-
pared between right and left femoral arteries. The principal
findings of this study are: 1) average plaque size in the right
femoral artery correlated with average plaque size in the left
artery; 2) in 32 of 42 individuals (76%) similarity concerning
the presence or absence of a significant correlation between
plaque area and IEL area was observed between right and
left femoral arteries; 3) there was concordance between both
arteries concerning the number of lipid-rich plaques; and 4)
the extent of inflammation in one femoral artery was not
concordant with the extent in the contralateral artery.
Plaque size. Atherosclerotic lesions preferentially develop
in lesion-prone areas such as bifurcations. However, the
gradual growth of plaques is predominantly influenced by
risk factors that affect the entire vascular system, such as
gender, age, hypertension and hypercholesterolemia. Our
observation of an association in average plaque size between
both arteries is consistent with the results of previous ultra-
sound studies where an association was found between the
intimal-medial thickness of right and left carotid arteries (8).
Arterial remodeling. It is unclear whether systemic factors
play a role in the mechanisms underlying de novo athero-
sclerotic remodeling. The present data show that in the
majority of the individuals, right and left femoral arteries
had similar expansive remodeling in response to plaque
formation. This result suggests a role for systemic factors.
The mechanisms involved in remodeling of de novo
atherosclerotic arteries are largely unknown. It has been
postulated that increased shear stress due to encroachment
of the plaque into the lumen underlies expansive remodeling
(1). Systemic factors that impair the natural endothelial
response to alterations in shear stress might lead to failure of
the compensatory enlargement response or even to shrink-
age of the artery. Evidence for a role of systemic factors in
arterial remodeling has been provided in recent studies,
where constrictive remodeling in culprit lesions was found
to be associated with systemic factors such as smoking status
(9,10) and insulin-treated diabetes mellitus (11). In both
animal (12) and clinical (10) studies, hypercholesterolemia
has been associated with expansive remodeling. Genetic
factors might also play a role.
Plaque vulnerability. LIPID-RICH PLAQUES. Plaques with a
large lipid-rich core have been associated with thrombus
formation (4) and are considered to have a high suscepti-
bility to rupture. We observed concordance between right
and left femoral arteries considering the number of lipid-
rich plaques, suggesting that systemic factors play a role in
the formation of a large extracellular lipid pool.
A systemic factor that might be associated with lipid-rich
plaques is hypercholesterolemia. It has been demonstrated
that cholesterol-lowering therapy reduces the risk of acute
coronary events, especially in secondary-prevention trials
(13). A recent autopsy study showed that among men with
coronary disease who died suddenly, elevated ratios of total
cholesterol to high density lipoprotein cholesterol predis-
pose patients to rupture of vulnerable plaques (14). Effects
of reduction of serum cholesterol level on composition of
Table 2. Number of Plaques in Which Lipid-Rich Core
Occupies $40% of Total Plaque Area in Right and Left
Femoral Arteries
Left Femoral
Artery
Right Femoral Artery
0–1 2–6
0–1 13 (43%) 3 (10%)
2–6 3 (10%) 11 (37%)
Agreement 80%, kappa 5 0.60 (p 5 0.001).
Table 3. Number of Plaques With Superficial Inflammation in
Right and Left Femoral Arteries
Left Femoral
Artery
Right Femoral Artery
0–1 2–4 5–6
0–1 2 (8%) 8 (31%) 1 (4%)
2–4 2 (8%) 9 (35%) 2 (8%)
5–6 0 (0%) 1 (4%) 1 (4%)
Agreement 46%, kappa 5 0.067 (p 5 0.61). Superficial inflammation: staining of
CD68 and/or CD45RO in cap and/or shoulder.
Figure 3. Example of a vulnerable plaque with a large lipid-rich core and
local minor picrosirius red staining of the cap confirmed by polarized light
microscopy (A and B) and staining of CD68 in the cap and shoulder (C).
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the plaque have been shown in a rabbit model (15). In this
model, a long-term reduction of serum low density lipopro-
tein cholesterol resulted in a decrease of the area of
macrophages plus extracellular lipid deposits in favor of
collagen.
PLAQUE INFLAMMATION. Inflammation of the cap is con-
sidered an important mechanism underlying cap destruction
(3). Evidence for a role of inflammation in plaque rupture
has been demonstrated by colocalization of inflammation
and plaque rupture sites (7). No association was observed in
the extent of inflammation between right and left femoral
arteries. This could be interpreted as a nonhomogeneous
distribution of inflammation in atherosclerotic arteries. The
fact that inflammation in atherosclerotic lesions seems to be
present with local preference suggests that plaque inflam-
mation is locally affected. Evidence for local immunologic
activation has been provided by the demonstration of
activated T lymphocytes and macrophages (7) and extensive
expression of human leucocyte antigen class II molecules in
the atherosclerotic plaque (16). Local antigens could be
autoantigens (17) or antigens of infectious agents, like Chla-
mydia pneumoniae (18).
Systemic markers of inflammation, such as C-reactive
protein (CRP), have been associated with atherosclerosis
and its thrombotic complications (19). A systemically de-
termined risk marker such as CRP may reflect cumulation
of all inflammation in the arterial system, independent of
the distribution in the circulation. The association between
systemic risk markers and a thrombotic event is then a
matter of chance; the more inflammation present, the more
plaques may rupture with subsequent thrombotic occlusion
of the lumen.
The present results suggest that plaque inflammation is
locally affected and that arterial remodeling is influenced by
systemic factors. These observations seem to contradict the
results of a previous study of our group. In a postmortem
histology study an association between local arterial remod-
eling and the vulnerability of the atherosclerotic plaque was
demonstrated (20). Moreover, intravascular ultrasound
studies showed a correlation between culprit lesion remod-
eling and the clinical course of coronary artery disease
(21,22) and target lesion revascularization after nonstent
intervention (23). However, in these previous studies arte-
rial remodeling was studied locally, whereas in the present
study systematic arterial remodeling along the artery was
studied. Therefore, the present observation does not exclude
an association between local plaque composition and arterial
remodeling.
Study limitations. The present study was performed in
femoral arteries. It is unknown whether the present results
can be extrapolated to the coronary arteries. The femoral
artery hardly tapers (6) and has no major side branches,
which makes it ideal to study geometric remodeling. Results
of studies of atherosclerotic remodeling in the short arterial
segments of coronary arteries, however, are consistent with
findings in the femoral artery (2,20,22,24,25). The preva-
lence of inflammation of atherosclerotic plaques was also
found to be comparable for coronary and femoral arteries (5).
The age of the studied population was high, and it is
unknown whether the present results can be extrapolated to
younger individuals. Previously, however, we demonstrated
(6) that the prevalence of the different modes of arterial
remodeling in a high-age patient group was comparable
with a lower age population suffering from claudication.
Summary. These results suggest that not only plaque
burden, but also vascular remodeling and lipid deposition in
plaques, are influenced by systemic factors. The nonhomo-
geneous distribution of inflammation in atherosclerotic
arteries supports the hypothesis that plaque inflammation is
locally affected. These data suggest that the development of
rupture-prone plaques is a complicated process that is
influenced by both systemic and local factors.
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